Adjusted EBITDA for fiscal Q4 2025 (period ended Dec. 31, 2025) -- $94.8 million, down from $97.8 million in fiscal Q4 2024, ...

aFPAR (Analog of Fully Processed Active Recombinant): Descriptor for synthetic or recombinant versions of biologic active ...

Good morning, and welcome to Permian Resources Conference Call to discuss its Fourth Quarter and Full Year 2025 Earnings. Today's call is being recorded. A replay of the call will be accessible until ...

Consolidated revenue grew 12%, supported by meaningful gross margin expansion and stronger double-digit growth in adjusted EBITDA and operating cash flow. That momentum continued through the fourth ...

New AI capabilities drive smarter automation, enriched metadata, and assisted workflow design for live and file-based ...

As Hillary Clinton fields Epstein questions behind closed doors, the War Department leans on Silicon Valley to loosen AI ...

Q4 2025 Management View CEO Gajen Kandiah emphasized a sharpened strategy in response to the market's shift towards AI at scale within enterprise systems, stating "Organizations now expect AI to ...

We continue to execute with momentum and operating discipline, and we are reinforcing the scale of our platform as we build a modern energy portfolio. With that as context, let me start with the ...

Christina Gentry, DVM, DACVM, discusses dermatologic signs that a patient is in need of immediate attention, including ...